Evidence map›Paper›PMID 11879194›Full record

ArticleThe Biochemical journal2002

Sorbitol activates atypical protein kinase C and GLUT4 glucose transporter translocation/glucose transport through proline-rich tyrosine kinase-2, the extracellular signal-regulated kinase pathway and phospholipase D.

Mini P Sajan, Gautam Bandyopadhyay, Yoshinori Kanoh, Mary L Standaert, Michael J Quon, Brent C Reed, Ivan Dikic, Robert V Farese

Open access · bronzeAbstract read
In one paragraph

Article in The Biochemical journal, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mini P SajanJ.A. Haley Veterans' Hospital Research Service and Department of Internal Medicine, University of South Florida College of Medicine, 13000 Bruce B. Downs Blvd., Tampa, FL 33612, U.S.A.
Gautam Bandyopadhyay
Yoshinori Kanoh
Mary L Standaert
Michael J Quon
Brent C Reed
Ivan Dikic
Robert V Farese
Ludwig Cancer Research · SE

Funding

Activation of Atypical PKC by Insulin and Other AgonistsR01DK065969 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI FARESE, ROBERT V · 2004 to 2014
$2.8M
Insulin Signaling And Gene Regulation In Transfected Adipose CellsZ01AT000002 · NCCIH · NATIONAL CENTER FOR COMPLEMENTARY & INTEGRATIVE HEALTH · PI QUON, MICHAEL J. · 2002 to 2008
$863k
LIPID REGULATED KINASES IN INSULIN ACTIONR01DK038079 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI FARESE, ROBERT V · 1987 to 2001
$373k
NIDDK NIH HHS 2R01 DK 38079-091ANIDDK NIH HHS R01 DK065969
6 · The paper itself

Abstract

Sorbitol, "osmotic stress", stimulates GLUT4 glucose transporter translocation to the plasma membrane and glucose transport by a phosphatidylinositol (PI) 3-kinase-independent mechanism that reportedly involves non-receptor proline-rich tyrosine kinase-2 (PYK2) but subsequent events are obscure. In the present study, we found that extracellular signal-regulated kinase (ERK) pathway components, growth-factor-receptor-bound-2 protein, son of sevenless (SOS), RAS, RAF and mitogen-activated protein (MAP) kinase/ERK kinase, MEK(-1), operating downstream of PYK2, were required for sorbitol-stimulated GLUT4 translocation/glucose transport in rat adipocytes, L6 myotubes and 3T3/L1 adipocytes. Furthermore, sorbitol activated atypical protein kinase C (aPKC) through a similar mechanism depending on the PYK2/ERK pathway, independent of PI 3-kinase and its downstream effector, 3-phosphoinositide-dependent protein kinase-1 (PDK-1). Like PYK2/ERK pathway components, aPKCs were required for sorbitol-stimulated GLUT4 translocation/glucose transport. Interestingly, sorbitol stimulated increases in phospholipase D (PLD) activity and generation of phosphatidic acid (PA), which directly activated aPKCs. As with aPKCs and glucose transport, sorbitol-stimulated PLD activity was dependent on the ERK pathway. Moreover, PLD-generated PA was required for sorbitol-induced activation of aPKCs and GLUT4 translocation/glucose transport. Our findings suggest that sorbitol sequentially activates PYK2, the ERK pathway and PLD, thereby increasing PA, which activates aPKCs and GLUT4 translocation. This mechanism contrasts with that of insulin, which primarily uses PI 3-kinase, D3-PO(4) polyphosphoinositides and PDK-1 to activate aPKCs.

Indexed as

Muscle Proteins3T3 CellsAdipocytesAndrostadienesAnimalsCells, CulturedDantroleneEnzyme ActivationEnzyme InhibitorsEpididymisFlavonoidsFocal Adhesion Kinase 2Glucose Transporter Type 4MaleMAP Kinase Signaling SystemMice2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-oneAndrostadienesDantroleneEnzyme InhibitorsFlavonoidsFocal Adhesion Kinase 2Glucose Transporter Type 4Mitogen-Activated Protein KinasesMonosaccharide Transport ProteinsMuscle ProteinsPhospholipase DProtein Kinase CProtein-Tyrosine KinasesPtk2b protein, mousePtk2b protein, ratRecombinant ProteinsSlc2a4 protein, mouseSlc2a4 protein, ratSorbitolWortmannin

Identifiers

PMID11879194
PMCPMC1222431
OpenAlexW2032158701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.